HENDERSON NV / ACCESSWIRE / April 11, 2019 / With the market off to its best first quarter over the past 2 decades and the cannabis industry being one of the hottest in the market, now is an ideal time to research cannabis stocks. Today, we are highlighting a few cannabis stocks that aren't necessarily known as cannabis stocks but are beneficiaries of the industry nonetheless.
CleanSpark, Inc. (CLSK) is a microgrid cleantech play that could help solve cannabis' major energy issue. The company has developed a microgrid power solution for the cannabis industry, which can reduce energy costs by up to 82%. This represents a huge potential revenue stream for the company. Due to this fact the company has stated that marketing to cannabis companies is one of their top initiatives for 2019. Recently, the company closed on $5 million round of funding, engaged a firm to navigate their up listing, and as far as currently operation go, announced the near completion of a $900k contract to install a CLSK microgrid at a U.S. Marine Corps Base and have been progressing on a $18.3 million deal with NYSE company MAC. This could be big, so start your research today.
Today we are highlighting: CleanSpark, Inc. (CLSK), Scotts Miracle-Gro Company (SMG), Emerald Health Therapeutics, Inc. (EMHTF), 22nd Century Group, Inc. (XXII), and TILT Holdings, Inc. (SVVTF).
In recent news, CleanSpark, Inc. (CLSK) (Market Cap: $146.401M; Share Price: $3.40) announced that it has delivered approximately $357,000 in custom electrical equipment to customers and received new orders of approximately $438,000 since the closing of the definitive agreement on January 22, 2019 to acquire the intellectual property of Pioneer Critical Power Inc. The custom equipment backlog has increased to approximately $3.9 million, an increase of approximately 8.3% from the backlog levels on the date of acquisition. Their acquisition of intellectual property of Pioneer Critical Power Inc., has already been a boon for their bottom line.
Scotts Miracle-Gro Company (SMG) (Market Cap: $4.506B; Share Price: $81.41) is one of the world's largest marketers of branded consumer products for lawn and garden care. It has entered the cannabis industry through its wholly-owned subsidiary The Hawthorne Gardening Company, for which it went on a shopping spree with a string of acquisitions. In 2018, it had acquired assets of Sunlight Supply Inc., which is the largest distributor of hydroponic products in the United States. Now, Hawthorne is the largest supplier of hydroponics solutions to U.S. marijuana growers. The company also supplies products including fertilizers, lighting systems, irrigation systems, and ventilation systems.
Emerald Health Therapeutics, Inc. (EMHTF) (Market Cap: $473.301M; Share Price: $3.34) announced on April 9 that its Québec facility, Verdélite, has received its Standard Processing License from Health Canada. This license means that, in addition to Verdélite's right to cultivate and sell cannabis flowers, it can now extract, manufacture, synthesize, test and sell next-generation cannabis products and will position Verdélite to launch these products in conjunction with the expected legalization of a broader spectrum of cannabis products in Canada in October 2019. The license also allows Verdélite to build and operate a laboratory for research and development of cannabis-based products. Formerly known as Agro-Biotech, Verdélite currently produces high-grade dried cannabis for medical and adult-use purposes. Emerald Health Therapeutics, Inc. is a Canadian licensed producer of cannabis.
22nd Century Group, Inc. (NYSE American: XXII) (Market Cap: $235.575M; Share Price: $1.89), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced that the company has entered into a worldwide strategic research and development agreement with KeyGene, a global leader in plant research involving high-value genetic traits and increased crop yields. This exclusive, worldwide collaboration will focus on developing hemp/cannabis plants with exceptional cannabinoid profiles for medical and therapeutic use among other applications. It had recently announced that the 2018 Farm Bill will greatly enhance the company's research activities around low-THC Cannabis sativa L.
TILT Holdings, Inc. (SVVTF) (Market Share: $197.451M; Share Price: $1.909) announced changes to its board of directors, including the resignations of Michael Orr and Todd Halpern and the pending appointments of Robert Calhoun and Mark Scatterday, subject to the approval of the Board on April 17, 2019 and the approval of the Canadian Securities Exchange.
It recently announced that the City Council of Taunton, Massachusetts voted 8-1 to grant a special permit to operate an adult-use cannabis manufacturing facility to Commonwealth Alternative Care ("CAC"), an indirect wholly owned subsidiary of TILT. The permit allows a 19,602 square foot adult-use manufacturing facility at 16 Mozzone Boulevard, adjacent to TILT's existing world-class cultivation, processing and dispensary facility at 30 Mozzone Boulevard, and will significantly enhance the company's capacity to produce high-quality infused cannabis products at scale. The facility expansion will also enable the implementation of high-end automated manufacturing and packaging equipment, further allowing TILT to deliver end-to-end services and customer solutions to cannabis businesses.
TILT is a leading provider of products and services to businesses operating in the cannabis industry. The company offers the contract manufacturing of marijuana in a variety of form factors, vaporizer and inhalation devices, business and consumer delivery services and a broad suite of software products for over 1,500 retailers and brands throughout the United States ("U.S."), Canada and Europe.
Priyanka Goel, CFA
This article was written by Regal Consulting, LLC (“Regal Consulting”). Regal Consulting has agreed to a three-month term consulting agreement with CLSK dated 9/12/18. The agreement calls for $10,000 in cash, and 30,000 restricted 144 shares of CLSK per month. Regal and CLSK have signed an amendment to extend the contract for twelve months starting 10/10/18, and increased the cash component to $20,000 per month. CLSK has paid an additional $12,000 for services provided in November. CLSK has paid an additional $88,000 for services provided in December. CLSK has paid an additional $100,000 for services for January. CLSK has paid an additional $100,000 for services for February. Regal was paid an additional $100,000 for March services. CLSK has paid an additional $100,000 for services for March. CLSK has paid an additional $30,000 for services for April. CLSK has paid All payments were made directly by Clean Spark, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. CLSK was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.
Full Legal Disclaimer Click Here.
Company Name: ACR Communication LLC.
Contact Person: Media Manager
Country: United States
SOURCE: ACR Communication LLC
View source version on accesswire.com: